rumor was wrong about P ===================== Is good to see a story about Oral PsO but it isn't Prurisol -- the placebo #s off as you flagged -- also the 26 weeks vs our 16 weeks timeline
Still -- story does show why Orals, like Otezla, can command a substantial part of the market ... 2bn -- pill so much easier to administer
An interview w Dr Forman - about 10.20m in he's asked about an Oral drug trial he's participating in... goes right into talking about JAK inhibitor
So there must be a JAK PsO drug, not Tofacitinib, in testing (Pfizer... failed in PsO due to side effects, but a Go in UC, even if unimpressive #s -- 18% vs 6% active to placebo)